Trattamento con interferone beta 1b (IFN Beta 1b) e azatioprina nella sclerosi multipla relapsing remitting. Valutazione clinica e di qualita di vita

Translated title of the contribution: Treatment with Interferon beta 1b and Azathioprine in the relapsing- remitting MS. Clinical and quality of life evaluation

Roberto Palumbo, Andrea Salmaggi, Loredana L A Mantia, Alessandra Solari, Clara Milanese

Research output: Contribution to journalArticlepeer-review

Abstract

We prospectively evaluated relapse frequency and quality of life as assessed by the MS-QOL-54 questionnaire in 2 groups of relapsing-remitting MS patients with similar pre-treatment relapse rate and treated either with azathioprine or with beta IFN1b for one year. A marked reduction in relapse frequency occurred in both groups; no significant shifts occurred in the quality of life measurement. The results suggest further randomized studies of azathioprine and IFN beta in the therapy of relapsing-remitting MS.

Translated title of the contributionTreatment with Interferon beta 1b and Azathioprine in the relapsing- remitting MS. Clinical and quality of life evaluation
Original languageItalian
Pages (from-to)519-521
Number of pages3
JournalRivista di Neurobiologia
Volume45
Issue number5-6
Publication statusPublished - 1999

ASJC Scopus subject areas

  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Treatment with Interferon beta 1b and Azathioprine in the relapsing- remitting MS. Clinical and quality of life evaluation'. Together they form a unique fingerprint.

Cite this